National Health Investors closed at $71.62 on Nov 4, up 4.14%, 21.3% below its 52-week closing high. Volume of 117.2K shares was 0.45× its 20-day average (below normal).
Split-adjusted performance: +9.3% over one month, -3.1% over six months, -4.1% over one year.
In the quarter ended Jun 30, 2026, revenue was $121.32M, up 33.8% from a year earlier, with a net margin of 45.8%.
Short interest was 2.2M shares at the Oct 15 settlement, down 6.8% from the prior report (4.7% of float, 6.6 days to cover).